A randomized controlled trial of the effects of nurse case manager and community health worker team interventions in urban African-Americans with type 2 diabetesGARY, Tiffany L; BATTS-TURNER, Marian; MCGUIRE, Maura et al.Controlled clinical trials. 2004, Vol 25, Num 1, pp 53-66, issn 0197-2456, 14 p.Article

Adjustment for baseline measurement error in randomized controlled trials induces biasCHAN, Siew F; MACASKILL, Petra; IRWIG, Les et al.Controlled clinical trials. 2004, Vol 25, Num 4, pp 408-416, issn 0197-2456, 9 p.Article

Bayesian sample size calculations in phase II clinical trials using informative conjugate priorsMAYO, Matthew S; GAJEWSKI, Byron J.Controlled clinical trials. 2004, Vol 25, Num 2, pp 157-167, issn 0197-2456, 11 p.Article

Multicenter trial of early treatment for retinopathy of prematurity: study designControlled clinical trials. 2004, Vol 25, Num 3, pp 311-325, issn 0197-2456, 15 p.Article

Samples of exact k-stage group sequential designs for Phase II and Pilot studiesKEPNER, James L; CHANG, Myron N.Controlled clinical trials. 2004, Vol 25, Num 3, pp 326-333, issn 0197-2456, 8 p.Article

The utility of partial cross-over designs in early phase randomized prevention trialsHUTSON, Alan D; REID, Mary E.Controlled clinical trials. 2004, Vol 25, Num 5, pp 493-501, issn 0197-2456, 9 p.Article

Design and analysis of clinical trials with a bivariate failure time endpoint, with application to AIDS Clinical Trials Group Study A5142DIRIENZO, A. Gregory; DEGRUTTOLA, Victor.Controlled clinical trials. 2003, Vol 24, Num 2, pp 122-134, issn 0197-2456, 13 p.Article

Sample sizes for comparing means of two lifetime distributions with type II censored data: application in an aging intervention studyCHENGJIE XIONG; YAN YAN; MING JI et al.Controlled clinical trials. 2003, Vol 24, Num 3, pp 283-293, issn 0197-2456, 11 p.Article

Unique roles of a data and safety monitoring board in vaccine safety trials with compressed timelines and urgent implicationsSCHEIFELE, David; DUVAL, Bernard; DE SERRES, Gaston et al.Controlled clinical trials. 2003, Vol 24, Num 1, pp 99-104, issn 0197-2456, 6 p.Article

A matter of life and death? The Heart Protection Study and protection of clinical trial participantsMIGRINO, Raymond Q; TOPOL, Eric J.Controlled clinical trials. 2003, Vol 24, Num 5, pp 501-505, issn 0197-2456, 5 p.Article

Research staff turnover and participant adherence in the Women's Health InitiativeJACKSON, Marie; BERMAN, Nancy; HUBER, Margaret et al.Controlled clinical trials. 2003, Vol 24, Num 4, pp 422-435, issn 0197-2456, 14 p.Article

Sample size for K 2 x 2 tables in equivalence studies using Cochran's statisticSONG, James X; WASSELL, James T.Controlled clinical trials. 2003, Vol 24, Num 4, pp 378-389, issn 0197-2456, 12 p.Article

Choosing an equivalence limit for noninferiority or equivalence studiesWIENS, Brian L.Controlled clinical trials. 2002, Vol 23, Num 1, pp 2-14, issn 0197-2456Article

Drug distribution for a large crossover trial of the safety of inactivated influenza vaccine in asthmaticsHOLBROOK, Janet T; WISE, Robert A; GERALD, Lynn B et al.Controlled clinical trials. 2002, Vol 23, Num 1, pp 87-92, issn 0197-2456Article

Implementing the EGASIS trial, an international multicenter acute intervention trial in strokeVAN RAAK, Lisette; HILTON, Anne; KESSELS, Fons et al.Controlled clinical trials. 2002, Vol 23, Num 1, pp 74-79, issn 0197-2456Article

Quality assurance of asthma clinical trialsMALMSTROM, Kerstin; PESZEK, Iza; BOTTO, Al et al.Controlled clinical trials. 2002, Vol 23, Num 2, pp 143-156, issn 0197-2456Article

Regulatory approvals in a large multinational clinical trial: the ESPRIT experienceMCNAY, Laura A; TAVEL, Jorge A; OSEEKEY, Karen et al.Controlled clinical trials. 2002, Vol 23, Num 1, pp 59-66, issn 0197-2456Article

The bivariate continual reassessment method: extending the CRM to phase I trials of two competing outcomesBRAUN, Thomas M.Controlled clinical trials. 2002, Vol 23, Num 3, pp 240-256, issn 0197-2456Article

The dangers of inferring treatment effects from observational data: a case study in HIV infectionDUNN, David; BABIKER, Abdel; HOOKER, Malcolm et al.Controlled clinical trials. 2002, Vol 23, Num 2, pp 106-110, issn 0197-2456Article

Design and analysis of two-period studies of potentially disease-modifying treatmentsMCDERMOTT, Michael P; HALL, W. J; OAKES, David et al.Controlled clinical trials. 2002, Vol 23, Num 6, pp 635-649, issn 0197-2456, 15 p.Article

Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: the outcomes research and economic analysis components of the PROSPER trialAVORN, Jerry; BENNER, Josh; WANG, Philip S et al.Controlled clinical trials. 2002, Vol 23, Num 6, pp 757-773, issn 0197-2456, 17 p.Article

The Improving Primary Care of African Americans with Diabetes (IPCAAD) project: rationale and designPHILLIPS, Lawrence S; HERTZBERG, Vicki S; LYLES, Robert H et al.Controlled clinical trials. 2002, Vol 23, Num 5, pp 554-569, issn 0197-2456, 16 p.Article

Clinical Trials for drug registrations in Asian-Pacific countries : Proposal for a new paradigm from a statistical perspectiveWEICHUNG JOE SHIH.Controlled clinical trials. 2001, Vol 22, Num 4, pp 357-366, issn 0197-2456Article

Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart attack trial (ALLHAT)PRESSEL, Sara; DAVIS, Barry R; LOUIS, Gail T et al.Controlled clinical trials. 2001, Vol 22, Num 6, pp 674-686, issn 0197-2456Article

Attrition and retention of ethnically diverse subjects in a multicenter randomized controlled research trialJANSON, Susan L; ALIOTO, Maria Elena; BOUSHEY, Homer A et al.Controlled clinical trials. 2001, Vol 22, Num 6, pp 236S-243S, issn 0197-2456, SUPArticle